Releviate Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10210 Campus Point Dr Ste 150, San Diego...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Releviate Therapeutics
Founded in 2020, Releviate? Therapeutics is a bio-pharmaceutical company addressing the needs of patients suffering from neuropathic pain. Our treatment strategy deploys specific human monoclonal antibodies to inactivate certain matrix metalloproteinases - MMP-9 and MMP-14 - and potentially improve patient outcomes. Unlike traditional neuropathic pain medication strategies, Releviate Therapeutics directly targets pain with antibodies whose development is rooted in actual pain pathophysiology. This first in class therapy will likely reverse underlying pathophysiology leading to the neuropathic pain. Initial indications address small fiber neuropathy and diabetic neuropathy.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Releviate Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Releviate Therapeutics launches new products
Check if Releviate Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Releviate Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Releviate Therapeutics
Releviate Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Releviate Therapeutics recently announced quarterly report
Click to see if Releviate Therapeutics had a recent Job posting/layoffs
Check out if Releviate Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Releviate Therapeutics
Find 2 more new buyers
Compare Similar Companies to Releviate Therapeutics
Compare insights from companies similar to Releviate Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Releviate Therapeutics
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Releviate Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Releviate Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Releviate Therapeutics.
Releviate Therapeutics Tech Stack
A closer look at the technologies used by Releviate Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Releviate Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2020, Releviate? Therapeutics is a bio-pharmaceutical company addressing the needs of patients suffering from neuropathic pain. Our treatment strategy deploys specific human monoclonal antibodies to inactivate certain matrix metalloproteinases - MMP-9 and MMP-14 - and potentially improve patient outcomes. Unlike traditional neuropathic p... Read More
